Search Results 81-90 of 15172 for Inhibition
In tumors that overexpress the enzyme, ST8Sia6, a function of macrophages, is altered to inhibit immune response. "In some cancers overexpression of ST8Sia6 in ...
Akt inhibitor MK2206 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...
These inhibitors are a newer class of medicines used to treat hormone-receptor-positive and HER2-negative breast cancers. Dr. Chumsri says that while CDK 4/6 ...
Wilson JR, Garner EM, Mashayekhi M, Hubers SA, Ramirez Bustamante CE, Kerman SJ, Nian H, Shibao CA, Brown NJ. DPP4 (Dipeptidyl Peptidase-4) Inhibition ...
The purpose of this study is to evaluate the safety of SEVENFACT® when used to treat bleeding events in participants with Hemophilia A or B with inhibitors ...
Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...
In Part 1, 12 subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status will be treated and undergo pharmacokinetics (PK) blood ...
Immune checkpoint inhibitors and thyroid dysfunction: A case from the endocrine teaching clinics. Sept. 14, 2018. A 68-year-old man was referred to ...
Ceritinib, an inhibitor of multiple protein kinases, has approval from the U.S. Food and Drug Administration (FDA) to treat ALK gene rearrangement-positive non- ...
The purpose of this phase Ib trial studies the side effects of MDM2 inhibitor AMG-232 and radiation therapy in treating patients with soft tissue sarcoma. MDM2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.